4 completed, 1 recruiting. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Commerce: new trials by email Literature Review of Commerce trials Research Report on Commerce
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SNIFF Multi-Device Study 2 20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company), 40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company) - Mild Cognitive Impairment, Cognitive Impairment | Phase 2 | Completed | Wake Forest University Health Sciences | 13 | 2020-07-16 | 2026-10-07 |
| Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA gemcitabine and oxaliplatin., Afatinib - Gallbladder Carcinoma | Phase 2 | Recruiting | Shanghai Jiao Tong University School of Medicine | 102 | 2020-06-01 | 2024-10-16 |
| Building Sentences With Preschoolers Who Use AAC AAC Generative Language Intervention, Standard of Care / Business as Usual - Down Syndrome, Speech and Language Disorder | Phase 2 | Completed | University of Central Florida | 70 | 2018-05-11 | 2024-01-08 |
| Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia CBT, D-Cycloserine - Agoraphobia | Phase 2 | Completed | Charite University, Berlin, Germany | 73 | 2011-11-01 | 2014-05-19 |
| Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies Pralatrexate Injection, Gemcitabine Hydrochloride, Vitamin B12 - Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma | Phase 1 / Phase 2 | Completed | Acrotech Biopharma Inc. | 119 | 2007-05-01 | 2020-01-07 |
Agoraphobia (1) · Cognitive Dysfunction (1) · Down Syndrome (1) · Gallbladder Neoplasms (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Language Disorders (1) · Leukemia (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Lymphoma, T-Cell, Peripheral (1)
Acrotech Biopharma Inc. (1) · Charite University, Berlin, Germany (1) · Shanghai Jiao Tong University School of Medicine (1) · University of Central Florida (1) · Wake Forest University Health Sciences (1)
United States (3) · China (1) · Germany (1)
Michael Saunders, MD (1) · Suzanne Craft, PhD (1) · Yingbin Liu, PHD (1)
R01DC016321 (1)